-
MILWAUKEE, WI - Jul 25, 2019 - Chr. Hansen develops and produces cultures, enzymes, probiotics and natural colors for the food, confectionary, beverages, dietary supplements and animal feed industries
Jul 25, 2019
-
WASHINGTON, DC, UNITED STATES - Jul 24, 2019 -
Washington, DC, July 24, 2019-
How will important reform initiatives, such as the VALID Act, affect the transformation of "diagnostics driven" precision medicine? Regulatory and policy experts will share the latest milestones and projections during the Plenary Keynote Session at the Next Generation Dx Summit, August 20-22, 2019 in Washington, DC
Jul 24, 2019
-
ROYAL OAK, MI, UNITED STATES - Jul 18, 2019 - OncoCell MDx, an immunogenomics platform company specializing in the delivery of novel, noninvasive molecular diagnostic assays, today announced that Kirk Wojno, M
Jul 18, 2019
-
PRINCETON, NJ - Jul 18, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the entire staff from Compass Strategic Consulting (Compass) has joined Certaras Evidence & Access group
Jul 18, 2019
-
LONDON, UK - Jul 15, 2019 - A fast, accurate and low-cost test for blood potassium levels, which can be used at home and has the potential to improve the safety, health and lifestyle of tens of millions of people worldwide, is being developed by Kalium Diagnostics
Jul 15, 2019
-
LEICESTER, UNITED KINGDOM - Jul 11, 2019 - A new study conducted by UK researchers has shown the potential for a new blood test to not only diagnose human tuberculosis (TB) but also identify those at most risk of developing the disease, according to findings published in medical journal
Clinical Infectious Diseases
Jul 11, 2019
-
WASHINGTON, DC, UNITED STATES - Jul 10, 2019 - Responding to the growth of the global point-of-care (POC) diagnostics market, which is projected to exceed $38 billion by 2022 (MarketsandMarkets), Cambridge Healthtech Institute will expand opportunities to explore POC innovations during its eleventh annual Next Generation Dx Summit, taking place August 20-22, 2019 in Washington, DC
Jul 10, 2019
-
PRINCETON, NJ - Jul 9, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that it has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve equity in health for all people worldwide
Jul 9, 2019
-
ROYAL OAK, MI, UNITED STATES - Jul 9, 2019 - OncoCell MDxä, an immunogenomics platform company specializing in the delivery of novel, noninvasive molecular diagnostic assays, today announced the appointment of Christopher Thibodeau as its Chief Operating Officer
Jul 9, 2019
-
SAN DIEGO, CA - Jun 28, 2019 - San Diego, CA . . . .
BINDING SITE's
IMMUNOLOGICALS GROUP
is pleased to announce the addition of a new, purified monoclonal antibody to be used for the analysis and testing of the Rubella
Jun 28, 2019
-
PRINCETON, NJ - Jun 25, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – Dr
Jun 25, 2019
-
CAMBRIDGE, MA - Jun 19, 2019 - Shimmer Research, a global leader in wearable technology for research applications, and ClearSky Medical Diagnostics, a leader in analyzing wearable data for medical applications, today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical research
Jun 19, 2019
-
KIRKLAND, WA, UNITED STATES - Jun 19, 2019 - Resolution Bioscience, Inc., today announced that its Resolution HRD liquid biopsy assay is being developed as a companion diagnostic for niraparib, a PARP inhibitor that is currently being investigated for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) as part of a research collaboration with Janssen Research & Development, LLC (Janssen)
Jun 19, 2019
-
BERLIN, GERMANY - Jun 17, 2019 -
New Clinical Data Support the Utility of Epi proColon® Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome
- Minimally-invasive blood test could complement colonoscopy in high-risk LS patients who are non-compliant with colonoscopy screening recommendations or may develop precancerous lesions in the interval between colonoscopies -
BERLIN, June 17, 2019 (GLOBE NEWSWIRE) -- Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the "Company"), a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation biomarker technology, today reported new study results suggesting that Epi proColon®, a colorectal cancer screening test approved for patients who are unwilling or unable to be screened by recommended methods may also be an important complement to colonoscopy for CRC screening in patients with LS, a hereditary disease associated with a 10-80% increase in the risk of developing CRC
Jun 17, 2019
-
PRINCETON, NJ - Jun 19, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its Simcyp® physiologically-based pharmacokinetic (PBPK) modeling and simulation technology was used to demonstrate bioequivalence (BE) for the US Food and Drug Administration (FDA) approval of a complex generic drug on the agencys abbreviated new drug application (ANDA) pathway
Jun 12, 2019
-
HALIFAX, NS, CANADA - Jun 12, 2019 - Nova Scotia-based life sciences company Sona Nanotech Inc. has been named the Startup Canada Innovation Award winner for the Atlantic Canada region
Jun 12, 2019
-
GUILDFORD, UNITED KINGDOM - Jun 11, 2019 - The Amsterdam University Medical Center has won MR Solutions Image of the Year 2019 award for the best molecular research image
Jun 11, 2019
-
PRINCETON, NJ - Jun 10, 2019 - Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that its scientists will participate in 28 sessions at the Population Approach Group in Europe (PAGE) 2019 Annual Meeting
Jun 10, 2019
-
RICHMOND, VA, UNITED STATES - Jun 6, 2019 -
RICHMOND, Va. (June 6, 2019)
- BRAINBox Solutions today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company's BRAINBox TBI (Traumatic Brain Injury) test in development, the first to aid in both the diagnosis and prognosis of mild TBI (concussion)
Jun 6, 2019
-
SAN DIEGO, CA - Jun 4, 2019 - ~~San Diego, CA . . . . BINDING SITEs IMMUNOLOGICALS GROUP is pleased to announce the addition of two (2) new native Tick-Borne Encephalitis (TBE) viral antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and research applications
Jun 4, 2019